Advances in dissolution instrumentation and their practical applications
暂无分享,去创建一个
[1] David C. Sperry,et al. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. , 2006, Journal of Pharmacy and Science.
[2] A. Beckett,et al. Improved Hydrodynamics for USP Apparatus 2 , 1996 .
[3] J. Crison,et al. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics , 2011, Drug development and industrial pharmacy.
[4] N. Fotaki,et al. Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations , 2010 .
[5] Raimar Löbenberg,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Dissolution Behavior of Glibenclamide , 2000, Pharmaceutical Research.
[6] J. Polli,et al. Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system. , 1999, International journal of pharmaceutics.
[7] Xin He,et al. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro–in vivo correlation , 2012, Drug development and industrial pharmacy.
[8] G. Duchateau,et al. Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] W. Butler,et al. A flow-through dissolution method for a two component drug formulation where the actives have markedly differing solubility properties , 1998 .
[10] Vivian Gray,et al. The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance , 2009, Pharmaceutical Research.
[11] K. Iseki,et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.
[12] Clive G. Wilson,et al. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] N. Fotaki,et al. Biorelevant Dissolution Methods and Their Applications in In Vitro- In Vivo Correlations for Oral Formulations~!2009-09-14~!2009-11-02~!2010-04-29~! , 2010 .
[14] James A. Rogers,et al. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test , 1997 .
[15] Zongming Gao. Development of a Continuous Dissolution/Absorption System—a Technical Note , 2012, AAPS PharmSciTech.
[16] P. Gao,et al. Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic system , 2009 .
[17] Rolf Daniels,et al. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[18] G. Amidon,et al. Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus , 2012, Biopharmaceutics & drug disposition.
[19] R. Fisher,et al. Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[20] R. Parikh,et al. A Novel Multicompartment Dissolution Apparatus for Evaluation of Floating Dosage Form Containing Poorly Soluble Weakly Basic Drug , 2006 .
[21] Geert Verreck,et al. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] Eric Beyssac,et al. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] P. Kulinowski,et al. Magnetic Resonance Imaging and Image Analysis for Assessment of HPMC Matrix Tablets Structural Evolution in USP Apparatus 4 , 2010, Pharmaceutical Research.
[24] C. Goodman. United States Pharmacopeial Convention , 1988 .
[25] J. Brasseur,et al. A Novel in Vitro and Numerical Analysis of Shear-Induced Drug Release from Extended-Release Tablets in the Fed Stomach , 2005, Pharmaceutical Research.
[26] J. Dressman,et al. Forecasting the Oral Absorption Behavior of Poorly Soluble Weak Bases Using Solubility and Dissolution Studies in Biorelevant Media , 2002, Pharmaceutical Research.
[27] Bertil Abrahamsson,et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] L. Gladden,et al. In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[29] P. Armenante,et al. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms. , 2012, Journal of pharmaceutical sciences.
[30] Nikoletta Fotaki,et al. Biorelevant dissolution: Methodology and application in drug development , 2009 .
[31] Y. Ozaki,et al. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging. , 2010, International journal of pharmaceutics.
[32] F. Muzzio,et al. Shear-induced variability in the United States pharmacopeia apparatus 2: Modifications to the existing system , 2005, The AAPS Journal.
[33] S. Qureshi. Comparative Impact of Stirring and Shearing in Drug Dissolution Testing with USP Paddle and Crescent-Shaped Spindles , 2006 .
[34] J. Dressman,et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.
[35] M. Brewster,et al. Supersaturating drug delivery systems: fast is not necessarily good enough. , 2012, Journal of pharmaceutical sciences.
[36] A J Sederman,et al. MRI studies of the hydrodynamics in a USP 4 dissolution testing cell. , 2011, Journal of pharmaceutical sciences.
[37] Makoto Kataoka,et al. In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it. , 2011, Biological & pharmaceutical bulletin.
[38] P. Quist,et al. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution. , 2003, Journal of pharmaceutical and biomedical analysis.
[39] James A. Rogers,et al. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test , 1997 .
[40] Christopher S. Polster,et al. Use of artificial stomach-duodenum model for investigation of dosing fluid effect on clinical trial variability. , 2010, Molecular pharmaceutics.
[41] J. Dressman,et al. An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine , 2012, Pharmaceutical Research.
[42] Clive G. Wilson,et al. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[43] P. Kulinowski,et al. Novel Application of MRI Technique Combined with Flow-Through Cell Dissolution Apparatus as Supportive Discriminatory Test for Evaluation of Controlled Release Formulations , 2010, AAPS PharmSciTech.
[44] M. Wickham,et al. The Design, Operation, and Application of a Dynamic Gastric Model , 2012 .
[45] J. Dressman,et al. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.
[46] W. Weitschies,et al. A biorelevant dissolution stress test device – background and experiences , 2010, Expert opinion on drug delivery.
[47] D. J. Phillips,et al. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems , 2012, The Journal of pharmacy and pharmacology.
[48] Monique Alric,et al. Investigation of the Biopharmaceutical Behavior of Theophylline Hydrophilic Matrix Tablets Using USP Methods and an Artificial Digestive System , 2007, Drug development and industrial pharmacy.
[49] Werner Weitschies,et al. Investigation of the Dissolution Characteristics of Nifedipine Extended-Release Formulations Using USP Apparatus 2 and a Novel Dissolution Apparatus , 2009 .